{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:14:52Z","timestamp":1763644492173,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008702","name":"Kagoshima University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008702","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This study investigated the anti-inflammatory effect of clodronate, a vesicular nucleotide transporter (VNUT) inhibitor, on intestinal-failure-associated liver disease (IFALD) in a rat model of short bowel syndrome (SBS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The rats underwent jugular vein catheterization for continuous total parenteral nutrition (TPN) and 90% small bowel resection. The animals were divided into the following groups: TPN\/SBS (Control group), TPN\/SBS\/intravenous administration of low-dose clodronate (20\u00a0mg\/kg twice per week; Low group), or TPN\/SBS\/intravenous administration of high-dose clodronate (60\u00a0mg\/kg twice per week; High group). On day 7, the rats were euthanized. Hepatic steatosis and hepatocellular injury were also assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Hepatic steatosis and lobular inflammation in the liver were observed in all groups. The High group showed histologically reduced hepatic steatosis compared with the Control group. IL-6 and Nlrp3 expression in the High group was significantly suppressed compared to that in the Control group. The expression of other inflammatory cytokines tended to be lower in the High dose group than in the control group. The lipid metabolism gene expression in the liver specimens showed no significant differences among the groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The high-dose administration of clodronate may, therefore, inhibit hepatic steatosis and inflammation associated with IFALD in patients with SBS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00383-024-05858-y","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T23:35:00Z","timestamp":1731540900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Favorable inhibitory effect of clodronate on hepatic steatosis in short bowel syndrome model rats"],"prefix":"10.1007","volume":"40","author":[{"given":"Yudai","family":"Tsuruno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshiro","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Kedoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Hasuzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuru","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Bitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ieiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"issue":"2 Suppl 1","key":"5858_CR1","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1053\/j.gastro.2005.10.066","volume":"130","author":"DA Kelly","year":"2006","unstructured":"Kelly DA (2006) Intestinal failure-associated liver disease: what do we know today? Gastroenterology 130(2 Suppl 1):S70-77","journal-title":"Gastroenterology"},{"key":"5858_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/MPG.0b013e318268a9e3","volume":"56","author":"L D\u2019Antiga","year":"2013","unstructured":"D\u2019Antiga L, Goulet O (2013) Intestinal failure in children: the European view. J Pediatr Gastroenterol Nutr 56:118\u2013126","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5858_CR3","first-page":"5192","volume":"11","author":"N Hasuzawa","year":"2021","unstructured":"Hasuzawa N, Tatsushima K, Wang L, Kabashima M, Tokubuchi R, Nagayama A et al (2021) Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury. Sci Erp 11:5192","journal-title":"Sci Erp"},{"key":"5858_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11302-017-9568-1","volume":"13","author":"Y Moriyama","year":"2017","unstructured":"Moriyama Y, Hiasa M, Sakamoto S, Omote H, Nomura M (2017) Vesicular nucleotide transporter (VNUT): appearance of an actress on the stage of purinergic signaling. Purinergic Signal 13:387\u2013404","journal-title":"Purinergic Signal"},{"key":"5858_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1248\/bpb.b18-00408","volume":"42","author":"H Suzuki","year":"2019","unstructured":"Suzuki H, Bando K, Tada H, Kiyama T, Oizumi T, Funayama H et al (2019) Augmentation of lipopolysaccharide-induced production of IL-1\u03b1 and IL-1\u03b2 in mice given intravenous zoledronate (a nitrogen-containing bisphosphonate) and its prevention by clodronate (a non-nitrogen-containing bisphosphonate). Biol Pharm Bull 42:164\u2013172","journal-title":"Biol Pharm Bull"},{"key":"5858_CR6","doi-asserted-by":"publisher","first-page":"115715","DOI":"10.1016\/j.bone.2020.115715","volume":"143","author":"E McCloskey","year":"2021","unstructured":"McCloskey E, Paterson AH, Powles T, Kanis JA (2021) Clodronate Bone 143:115715","journal-title":"Clodronate Bone"},{"key":"5858_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jpedsurg.2023.11.028","volume":"59","author":"K Sugita","year":"2024","unstructured":"Sugita K, Yano K, Onishi S, Iwamoto Y, Ogata M, Takada L et al (2024) Superiority of intestinal adaptation by hepatocyte growth factor in the jejunum: an experimental study in a short-bowel rat model. J Pediatr Surg 59:627\u2013633","journal-title":"J Pediatr Surg"},{"key":"5858_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"5858_CR9","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20:3328","journal-title":"Int J Mol Sci"},{"key":"5858_CR10","doi-asserted-by":"publisher","first-page":"e20190347","DOI":"10.1084\/jem.20190347","volume":"217","author":"S Kang","year":"2020","unstructured":"Kang S, Narazaki M, Metwally H, Kishimoto Y (2020) Historical overview of the interleukin-6 family cytokine. J Exp Med 217:e20190347","journal-title":"J Exp Med"},{"key":"5858_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/eji.201040319","volume":"40","author":"CA Dinarello","year":"2010","unstructured":"Dinarello CA (2010) IL-1: discoveries, controversies and future directions. Eur J Immunol 40:599\u2013606","journal-title":"Eur J Immunol"},{"key":"5858_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, van der Meer JWM (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 11:633\u2013652","journal-title":"Nat Rev Drug Discov"},{"key":"5858_CR13","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.metop.2021.100138","volume":"12","author":"E Sozen","year":"2021","unstructured":"Sozen E, Demirel-Yalciner T, Sari D, Avcilar C, Samanci TF, Ozer NK (2021) Deficiency of SREBP1c modulates autophagy mediated lipid droplet catabolism during oleic acid induced steatosis. Metabol Open 12:100138","journal-title":"Metabol Open"},{"key":"5858_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1055\/s-0032-1321819","volume":"44","author":"MF Vitto","year":"2012","unstructured":"Vitto MF, Luz G, Luciano TF, Marques SO, Souza DR, Pinho RA et al (2012) Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice. Horm Metab Res 44:885\u2013890","journal-title":"Horm Metab Res"},{"key":"5858_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.metabol.2010.06.008","volume":"60","author":"T Muraoka","year":"2011","unstructured":"Muraoka T, Aoki K, Iwasaki T, Shinoda K, Nakamura A, Aburatani H et al (2011) Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet. Metabolism 60:617\u2013628","journal-title":"Metabolism"},{"key":"5858_CR16","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/ATVBAHA.110.219659","volume":"31","author":"T Karasawa","year":"2011","unstructured":"Karasawa T, Takahashi A, Saito R, Sekiya M, Igarashi M, Iwasaki H et al (2011) Arterioscler Thromb Vasc Biol 31:1788\u20131795","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5858_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2009.01.009","volume":"605","author":"B K\u00f6nig","year":"2009","unstructured":"K\u00f6nig B, Koch A, Spielmann J, Hilgenfeld C, Hirche F, Stangl GI et al (2009) Activation of PPARalpha and PPARgamma reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1. Eur J Pharmacol 605:23\u201330","journal-title":"Eur J Pharmacol"},{"key":"5858_CR18","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1210\/me.2002-0190","volume":"17","author":"T Yoshikawa","year":"2003","unstructured":"Yoshikawa T, Ide T, Shimano H, Yahagi N, Amemiya-Kudo M, Matsuzaka T et al (2003) Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Mol Endocrinol 17:1240\u20131254","journal-title":"Mol Endocrinol"},{"key":"5858_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3945\/jn.110.135210","volume":"141","author":"MA Abdelmegeed","year":"2011","unstructured":"Abdelmegeed MA, Yoo SH, Henderson LE, Gonzalez FJ, Woodcroft KJ, Song BJ (2011) PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. J Nutr 141:603\u2013610","journal-title":"J Nutr"},{"key":"5858_CR20","doi-asserted-by":"publisher","first-page":"166013","DOI":"10.1016\/j.bbadis.2020.166013","volume":"1867","author":"K Tatsushima","year":"2021","unstructured":"Tatsushima K, Hasuzawa N, Wang L, Hiasa M, Ashida SS, K, et al (2021) Vesicular ATP release from hepatocytes plays a role in the progression of nonalcoholic steatohepatitis. Biochim Biophys Acta Mol Basis Dis 1867:166013","journal-title":"Biochim Biophys Acta Mol Basis Dis"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-024-05858-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-024-05858-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-024-05858-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T17:03:56Z","timestamp":1734023036000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-024-05858-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5858"],"URL":"https:\/\/doi.org\/10.1007\/s00383-024-05858-y","relation":{},"ISSN":["1437-9813"],"issn-type":[{"type":"electronic","value":"1437-9813"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"16 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yudai Tsuruno and the other co-authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The datasets generated and\/or analyzed during the current study are available from the corresponding author upon reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}],"article-number":"307"}}